• linkedin
  • Increase Font
  • Sharebar

    The 5 Latest FDA Drug Approvals

    The FDA has already approved 24 new drugs in 2017.



    BAXDELA (delafloxacin), Melinta Therapeutics

    Indications: Treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by designated susceptible bacteria in adults.

    Dosage: 300 mg by intravenous infusion over 60 minutes, every 12 hours, or a 450-mg BAXDELA tablet orally every 12 hours for 5 to 14 days total duration.

    Contraindications: Known hypersensitivity to BAXDELA or other fluoroquinolones.

    Read the full label here

    Previous ButtonNext Button



    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available